Medirom Healthcare misses Form 20-F filing deadline, draws Nasdaq notice
Share
Listen to the news
Medirom Healthcare misses Form 20-F filing deadline, draws Nasdaq notice
  • Medirom received a Nasdaq notice for failing to timely file its Form 20-F for the year ended Dec. 31, 2025.
  • The notification cited noncompliance with Nasdaq Listing Rule 5250(c)(1); trading of its American Depositary Shares continues.
  • Nasdaq gave the company until July 27, 2026 to submit a compliance plan; an approved plan could extend the cure period to Nov. 11, 2026.
  • Compliance can be restored by filing the Form 20-F during the exception period; a rejected plan can be appealed to a Nasdaq hearings panel.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medirom Healthcare Technologies Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-248426), on May 29, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending